ARMISTICE CAPITAL, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Dermata Therapeutics, Inc. Common Stock, par value $0.0001 per share (DRMA)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Dermata Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: DRMA
Shares outstanding: 2,766,987 shares
Disclosed Ownership: 276,422 shares
Ownership: 10%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 17:41:56 UTC
Date of event: 31 Dec 2024
Next filing: 15 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	10%	276,422	0	276,422	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	10%	276,422	0	276,422	/s/ Steven Boyd	Steven Boyd